Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
NCT ID: NCT04907565
Last Updated: 2024-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
408 participants
OBSERVATIONAL
2021-09-21
2025-09-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese patients
BMI \>30kg/m2
Blood sampling
4 tubes of 7 mL of blood will be collected
white adipose tissue sampling
At the beginning of the surgery, samples of white adipose tissue from the surgical wound will be collected.
non obese patients
BMI between 18 to 29kg/m2
Blood sampling
4 tubes of 7 mL of blood will be collected
white adipose tissue sampling
At the beginning of the surgery, samples of white adipose tissue from the surgical wound will be collected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling
4 tubes of 7 mL of blood will be collected
white adipose tissue sampling
At the beginning of the surgery, samples of white adipose tissue from the surgical wound will be collected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with a MMSE score \> or = 20(/30),
* patient able to give informed consent
Exclusion Criteria
* patient with a known dementia or altered MMSE score (under 20)
60 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François Labaste, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purpan University Hospital
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
François Labaste, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/21/0014
Identifier Type: -
Identifier Source: org_study_id